Proprotein Convertase Subtilisin Kexin Type 9 PCSK9 as a New Biomarker for Coronary Artery Disease in an Australian Population

Pang, Jing (Investigator 01)
Watts, Gerald (Investigator 02)
McQuillan, Brendan (Investigator 03)
Chan, Dick (Investigator 04)
Barrett, Hugh (Investigator 05)

Status	Finished
Effective start/end date	1/01/14 → 31/12/14

Funding

Royal Perth Hospital Medical Research Foundation: A$15,500.00
Royal Perth Hospital Medical Research Foundation: A$15,500.00
Royal Perth Hospital Medical Research Foundation: A$15,500.00